Literature DB >> 9418629

Clinical pathway management of total knee arthroplasty.

J D Mabrey1, J S Toohey, D A Armstrong, L Lavery, L A Wammack.   

Abstract

Using a retrospective cohort study design, the authors examined complications, readmissions, morbidity and mortality, and function scores in two groups of patients attended by the same surgeon for the year before and the year after the implementation of an outcomes management program with clinical pathways for patients undergoing total knee arthroplasty at an academic health center. The effectiveness of the pathway constantly was adjusted using variance analysis and continuous quality improvement techniques. This program reduced the length of stay by 57% from a premanagement value of 10.9 +/- 5.4 days in 1994 (Group 1) to 4.7 +/- 1.4 days in 1996 (Group 2). Hospital costs (based on an inflation adjusted cost to charge ratio) for all total knees were reduced 11% from $13,328 +/- $3905 in 1994 to $11,862 +/- $4763 in 1996. Preoperative and postoperative knee scores were 41.1 +/- 16.3 and 84.2 +/- 16.0 for Group 1 and 42.5 +/- 13.0 and 87.0 +/- 10.4 for Group 2, respectively. There was no statistically significant difference between the preoperative or the postoperative knee scores of Groups 1 and 2. The application of clinical pathways, variance analysis, and continuous quality improvement toward the treatment of patients who had total knee arthroplasty at an academic health center resulted in significant savings in length of stay without adversely affecting overall outcome.

Entities:  

Mesh:

Year:  1997        PMID: 9418629

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  21 in total

1.  Preventable inpatient time: adequacy of electronic patient information systems.

Authors:  D L Katz; R Mazhari; R Kalus; H Nawaz
Journal:  Am J Public Health       Date:  1999-12       Impact factor: 9.308

2.  Jay Donald Mabrey, MD: a conversation with the editor. Interview by William Clifford Roberts.

Authors:  Jay Donald Mabrey
Journal:  Proc (Bayl Univ Med Cent)       Date:  2006-01

3.  Functional performance with a single-radius femoral design total knee arthroplasty.

Authors:  Enrique Gómez-Barrena; Carmelo Fernandez-García; Almudena Fernandez-Bravo; Raquel Cutillas-Ruiz; Gloria Bermejo-Fernandez
Journal:  Clin Orthop Relat Res       Date:  2010-05       Impact factor: 4.176

4.  Low complication rates in outpatient total knee arthroplasty.

Authors:  David A Crawford; Joanne B Adams; Keith R Berend; Adolph V Lombardi
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-05-18       Impact factor: 4.342

5.  Feasibility and safety of performing outpatient unicompartmental knee arthroplasty.

Authors:  Michael B Cross; Richard Berger
Journal:  Int Orthop       Date:  2013-12-13       Impact factor: 3.075

6.  Short-term outcomes of outpatient surgery for total knee arthroplasty.

Authors:  Muhammet Sadık Bilgen; Osman Yaray; Müren Mutlu; Ahmet İdris Çakır; Ömer Faruk Bilgen
Journal:  Singapore Med J       Date:  2018-12-17       Impact factor: 1.858

7.  Pre-operative patient education reduces length of stay after knee joint arthroplasty.

Authors:  Samantha Jones; Mustafa Alnaib; Michail Kokkinakis; Michael Wilkinson; Alan St Clair Gibson; Deiary Kader
Journal:  Ann R Coll Surg Engl       Date:  2011-01       Impact factor: 1.891

8.  The feasibility and perioperative complications of outpatient knee arthroplasty.

Authors:  Richard A Berger; Sharat K Kusuma; Sheila A Sanders; Elizabeth S Thill; Scott M Sporer
Journal:  Clin Orthop Relat Res       Date:  2009-02-24       Impact factor: 4.176

9.  Decreasing medical complications for total knee arthroplasty: effect of critical pathways on outcomes.

Authors:  M Elaine Husni; Elena Losina; Anne H Fossel; Daniel H Solomon; Nizar N Mahomed; Jeffrey N Katz
Journal:  BMC Musculoskelet Disord       Date:  2010-07-14       Impact factor: 2.362

10.  Effects of clinical pathways in the joint replacement: a meta-analysis.

Authors:  A Barbieri; K Vanhaecht; P Van Herck; W Sermeus; F Faggiano; S Marchisio; M Panella
Journal:  BMC Med       Date:  2009-07-01       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.